First Light Asset Management, LLC Ultragenyx Pharmaceutical Inc. Transaction History
First Light Asset Management, LLC
- $780 Million
- Q1 2025
A detailed history of First Light Asset Management, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, First Light Asset Management, LLC holds 632,033 shares of RARE stock, worth $17.8 Million. This represents 2.94% of its overall portfolio holdings.
Number of Shares
632,033
Previous 763,607
17.23%
Holding current value
$17.8 Million
Previous $32.1 Million
28.76%
% of portfolio
2.94%
Previous 3.14%
Shares
23 transactions
Others Institutions Holding RARE
# of Institutions
335Shares Held
89.6MCall Options Held
1.05MPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA10.2MShares$287 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$158 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$117 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$90.5 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$73.6 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $1.97B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...